SQY Therapeutics
PrivateLast Round
Grant
Nov 27, 2025
Total Funding Raised
$348,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SQY Therapeutics is a biotechnology company that develops antisense oligonucleotide therapies for the treatment of genetic diseases, particularly Duchenne muscular dystrophy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SQY Therapeutics Comparables
Compare SQY Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shift Pharmaceuticals | 81% | |
| Dyne Therapeutics | 78% | |
| Entrada Therapeutics | 76% | |
SQY Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 27, 2025 |
SQY Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Région Île-de-France | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 77% MoM.
- Apr 16, 2026
Monthly visitors increased 45% MoM.
SQY Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SQY Therapeutics's valuation, stock price, and market status.